Related Experiment Video
Updated: Jun 13, 2026

08:47
Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Structure of an apoptosome-procaspase-9 CARD complex
Shujun Yuan1, Xinchao Yu, Maya Topf
1Department of Physiology and Biophysics, Boston University School of Medicine, 700 Albany Street, Boston, MA 02118-2526, USA.
Structure (London, England : 1993)
|May 14, 2010
Summary
The apoptosome, crucial for programmed cell death, undergoes conformational changes during activation. This structural study reveals how Apaf-1 assembly enables procaspase-9 activation and explains mutation effects.
Area of Science:
- Molecular Biology
- Structural Biology
- Biochemistry
Background:
- Apaf-1 and cytochrome c form the apoptosome, activating procaspase-9 (pc-9) for apoptosis.
- Understanding apoptosome structure is key to deciphering cell death regulation.
Purpose of the Study:
- To determine the structure of the apoptosome-pc-9 CARD complex.
- To elucidate the conformational changes involved in pc-9 activation.
Main Methods:
- Site-directed thrombinolysis to remove pc-9 catalytic domains.
- Cryo-electron microscopy to determine the structure at ~9.5 Å resolution.
Main Results:
- A structural model of the apoptosome-pc-9 CARD complex was generated.
- Apaf-1 features tandem beta-propellers with docked cytochrome c.
- Apaf-1 CARDs transition from disordered to ordered upon pc-9 binding, forming a disk structure.
Conclusions:
- The study reveals conformational changes in Apaf-1 assembly critical for pc-9 activation.
- The model explains the impact of NOD mutations on the apoptosome's central hub.
Related Concept Videos
Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...

